The American College of Medical Genetics (ACMG) recommends that clinical laboratories report secondary findings in a defined list of genes. These findings are BEST described as:
-
A
Variants found incidentally that are unrelated to the reason for testing but have actionable health implications
-
B
All variants of uncertain significance found during sequencing
-
C
Variants associated with pharmacogenomics
-
D
Variants that are benign but of scientific interest